|
Market Closed -
Hong Kong S.E.
01:38:48 31/08/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 0.8000 HKD | 0.00% |
|
-11.60% | - |
| 03/08 | Fusen Pharmaceutical Company Limited Selected in National Centralised Medicines Procurement in China | CI |
| 26/06 | Fusen Pharma Gets Marketing Nod for Influenza Drug in China | MT |
| Market Cap | 51Cr 59Cr 7.54Cr 6.5Cr 6.09Cr 5.56Cr 10Cr 720.98Cr 11Cr 72Cr 28Cr 363.95Cr 28Cr 28Cr 1.21TCr | P/E 2024 |
-2.95x | P/E 2025 | -45.1x |
|---|---|---|---|---|---|
| Enterprise Value | 73Cr 85Cr 11Cr 9.34Cr 8.76Cr 8Cr 15Cr 1.04TCr 15Cr 103.94Cr 41Cr 523.13Cr 41Cr 40Cr 1.73TCr | EV / Sales 2024 |
2.83x | EV / Sales 2025 | 2.76x |
| Free-Float |
26.11% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 week | -11.60% | ||
| Current month | -20.79% | ||
| 1 month | -20.79% | ||
| 3 months | -26.61% | ||
| 6 months | -19.19% |
| 1 week | 0.76 |  | 0.87 |
| 1 month | 0.76 | | 1.15 |
| Current year | 0.68 | | 1.44 |
| 1 year | 0.32 | | 1.75 |
| 3 years | 0.24 | | 1.75 |
| 5 years | 0.24 | | 3.48 |
| 10 years | 0.24 | | 20 |
| Manager | Title | Age | Since |
|---|---|---|---|
Zhen Li
DFI | Director of Finance/CFO | 48 | 18/04/2019 |
Zhi Ming Cao
IRC | Investor Relations Contact | 40 | 18/01/2013 |
Yuk Hong Yeung
SEC | Corporate Secretary | 36 | 30/09/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Tai Sheng Hou
BRD | Director/Board Member | 63 | 07/04/2017 |
Yong Sheng Chi
BRD | Director/Board Member | 64 | 07/04/2017 |
Qing Fen Meng
BRD | Director/Board Member | 61 | 07/04/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 19/04/24 | Other | Chairman | 6,50,000 | 0.0867% | ||
| 18/04/24 | Other | Chairman | 2,40,000 | 0.0320% | ||
| 18/04/24 | Other | Chairman | 2,40,000 | 0.0320% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | -11.60% | +138.81% | -48.05% | 7.54Cr | |
| +3.38% | +3.92% | +26.96% | +78.55% | 4.82TCr | |
| +0.66% | +0.33% | +54.40% | +120.88% | 4TCr | |
| -2.49% | +5.21% | +17.18% | +85.56% | 1.24TCr | |
| -1.00% | -2.00% | -11.21% | +12.05% | 1.2TCr | |
| +0.19% | 0.00% | +29.35% | +150.00% | 934.62Cr | |
| -2.02% | -1.73% | +25.12% | +48.44% | 775.13Cr | |
| -1.39% | +3.74% | +28.71% | +223.40% | 742.6Cr | |
| -0.26% | +0.27% | +43.89% | -11.26% | 721.72Cr | |
| -0.53% | -1.53% | -36.09% | +17.02% | 530.08Cr | |
| Average | -0.35% | +0.42% | +31.71% | +67.66% | 1.5TCr | |
| Weighted average by Cap. | +0.78% | +1.41% | +29.19% | +88.60% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 33Cr 38Cr 4.85Cr 4.18Cr 3.92Cr 3.57Cr 6.73Cr 463.13Cr 6.75Cr 46Cr 18Cr 233.79Cr 18Cr 18Cr 775.19Cr | 27Cr 32Cr 4.06Cr 3.5Cr 3.28Cr 3Cr 5.65Cr 388.32Cr 5.66Cr 39Cr 15Cr 196.02Cr 15Cr 15Cr 649.98Cr |
| Net income | -19Cr -22Cr -2.81Cr -2.42Cr -2.27Cr -2.07Cr -3.9Cr -268.17Cr -3.91Cr -27Cr -10Cr -135.37Cr -11Cr -10Cr -448.87Cr | -1.18Cr -1.37Cr -17.51L -15.09L -14.15L -12.92L -24.33L -17Cr -24.41L -1.68Cr -65.5L -8.45Cr -65.76L -64.33L -28Cr |
| Net Debt | 37Cr 43Cr 5.46Cr 4.7Cr 4.41Cr 4.03Cr 7.58Cr 521.68Cr 7.61Cr 52Cr 20Cr 263.34Cr 20Cr 20Cr 873.19Cr | 22Cr 26Cr 3.3Cr 2.84Cr 2.67Cr 2.43Cr 4.58Cr 315.34Cr 4.6Cr 32Cr 12Cr 159.18Cr 12Cr 12Cr 527.83Cr |
Employees
1,005
Sector
Pharmaceuticals
Calendar
01:30pm
Earnings release - Q2 2026
| Date | Price | Change | Volume |
|---|---|---|---|
| 31/26/31 | HK$0.8000 | 0.00% | 1,000 |
| 28/26/28 | HK$0.8000 | 0.00% | 1,20,000 |
| 27/26/27 | HK$0.8000 | 0.00% | 0 |
| 26/26/26 | HK$0.8000 | 0.00% | 87,000 |
| 25/26/25 | HK$0.8000 | -11.60% | 3,62,000 |
- Stock Market
- Stocks
- 1652 Stock
Select your edition
All financial news and data tailored to specific country editions
